What We're Reading

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Pharma companies scramble to make deals with Trump after Pfizer scored White House praise

Architects of molecular cages win chemistry Nobel

Soufflé Therapeutics Gets Venture, Pharma Backing for Genetic Medicines

Will AI ever win its own Nobel? Some predict a prize-worthy science discovery soon

New York biotech firms face new hurdle as key federal funding program lapses

Trump slashed funding for universities that helped create these vital drugs

Nobel prize in medicine awarded to scientists for immune system research

Novo Plans to Make Obesity Pill Available Online Once Approved

Their parents never got them vaccinated. As young adults, they faced a choice.

AI has designed thousands of potential antibiotics. Will any work?

Alnylam Pulls TV Ad After Trump Crackdown on Drug Industry Spots

Biotech IPOs in Hong Kong far outpace the US driven by China’s buzzy biotech sector

The CDC still hasn’t issued COVID vaccine guidelines, leaving access in limbo

Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight

Why Pfizer’s Trump Deal Is Good News for All of Big Pharma

This Startup Wants to Put Its Brain-Computer Interface in the Apple Vision Pro

Patients Are Diagnosing Themselves With Home Tests, Devices and Chatbots

Pfizer’s deal ratchets up pressure on other drug companies

Scientists use cloning technology to swap DNA in human eggs

Trump’s USAID pause stranded lifesaving drugs. Children died waiting.

A drug made from marijuana reduced back pain in a large study

How the Brain Balances Excitation and Inhibition

$100,000 H-1B Fee Leaves Biopharma Grappling With Impact

Reach our audience

Related Publications

Don't miss tomorrow's biopharma industry news

Oct 08, 2025

Oct 07, 2025

Oct 06, 2025

Oct 03, 2025

Oct 02, 2025

Oct 01, 2025

Sep 30, 2025